B2DB — Who said what, where, and when

Napoleone Ferrara

Distinguished Professor of Pathology, Distinguished Adjunct Prof. of Ophthalmology and Pharmacology, University of California San Diego

Napoleone Ferrara is listed as Distinguished Professor of Pathology, Distinguished Adjunct Prof. of Ophthalmology and Pharmacology, University of California San Diego. Napoleone is scheduled to speak at American Society of Retina Specialists Annual Meeting 2027 on 28 July 2027.

Compiled from published conference agendas; not yet confirmed by Napoleone. Is this you? Claim this profile.

About

Napoleone Ferrara, MD, spent nearly 25 years at Genentech working on the isolation, cloning, and biological characterization of vascular endothelial growth factor (VEGF). This work resulted in the development of bevacizumab, the first anti-angiogenic agent approved by the Food and Drug Administration (FDA) for cancer therapy. His research also led to the development of ranibizumab, an anti-VEGF antibody fragment that provided the first effective therapy for neovascular age-related macular degeneration. In 2013, Dr. Ferrara joined the University of California, San Diego, where he has continued angiogenesis research.

Upcoming

American Society of Retina Specialists Annual Meeting 2027 28 July 2027 – 31 July 2027